RGEN

REPLIGEN CORP

Healthcare | Mid Cap

$0.37

EPS Forecast

$164.3

Revenue Forecast

Announcing earnings for the quarter ending 2025-03-31 soon
BLUEBluebird Bio IncDNLIDenali Therapeutics IncREPLReplimune Group IncTECHBio-techne CorpHALOHalozyme Therapeutics IncIOVAIovance Biotherapeutics IncNVAXNovavax IncCRSPCrispr Therapeutics AgNBIXNeurocrine Biosciences IncMRNAModerna Inc